health pharma news today obesity drugs glp-1 Popular medications may have benefits that extend beyond weight loss and blood sugar control, a new study finds RO LAUNCHES WEGOVY® PILL THROUGH
Description
Cambi MPC, Baretta GAP, Magro DDO, Boguszewski CL, Ribeiro IB, Jirapinyo P, de Moura DTH
[DOI] [PubMed] [Google Scholar] 130.Barale C., Buracco S., Cavalot F., Frascaroli C., Guerrasio A., Russo I
As awareness about newer treatment options rises among both healthcare professionals and patients, adoption of these therapies continues to expand
BARRIERS TO SWITCHING FROM ONE GLP1RA TO ANOTHER Patients may be reluctant to switch between GLP1RAs
